These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 42866

  • 1. [Prophylactic alkalization of the urine during cytostatic tumor treatment with the oxazaphosphorine derivatives, cyclophosphamide and ifosfamide].
    Brühl P, Hoefer-Janker H, Scheef W, Vahlensieck W.
    Onkologie; 1979 Jun; 2(3):120-4. PubMed ID: 42866
    [Abstract] [Full Text] [Related]

  • 2. The efficacy of mesna (2-mercaptoethane sodium sulfonate) as a uroprotectant in patients with hemorrhagic cystitis receiving further oxazaphosphorine chemotherapy.
    Andriole GL, Sandlund JT, Miser JS, Arasi V, Linehan M, Magrath IT.
    J Clin Oncol; 1987 May; 5(5):799-803. PubMed ID: 3106585
    [Abstract] [Full Text] [Related]

  • 3. Bladder urotoxicity pathophysiology induced by the oxazaphosphorine alkylating agents and its chemoprevention .
    Dobrek Ł, Thor PJ.
    Postepy Hig Med Dosw (Online); 2012 Sep 10; 66():592-602. PubMed ID: 23001201
    [Abstract] [Full Text] [Related]

  • 4. Prevention of ifosfamide-induced hemorrhagic cystitis by continuous bladder irrigation.
    Fujita J, Matsumoto K, Kakizoe T, Murase T.
    Urology; 1981 Sep 10; 18(3):250-1. PubMed ID: 7281389
    [Abstract] [Full Text] [Related]

  • 5. [Clinical evaluation of Mitexan in the prevention of urinary tract complications during treatment with Holoxan].
    Czownicki Z, Utracka-Hutka B.
    Nowotwory; 1981 Sep 10; 30(4):377-83. PubMed ID: 6792599
    [No Abstract] [Full Text] [Related]

  • 6. Acrolein, the causative factor of urotoxic side-effects of cyclophosphamide, ifosfamide, trofosfamide and sufosfamide.
    Brock N, Stekar J, Pohl J, Niemeyer U, Scheffler G.
    Arzneimittelforschung; 1979 Sep 10; 29(4):659-61. PubMed ID: 114192
    [Abstract] [Full Text] [Related]

  • 7. Urinary elimination of cyclophosphamide alkylating metabolites and free thiols following two administration schedules of high-dose cyclophosphamide and mesna.
    Fleming RA, Cruz JM, Webb CD, Kucera GL, Perry JJ, Hurd DD.
    Bone Marrow Transplant; 1996 Apr 10; 17(4):497-501. PubMed ID: 8722345
    [Abstract] [Full Text] [Related]

  • 8. Prevention of cyclophosphamide-induced hemorrhagic cystitis.
    Droller MJ, Saral R, Santos G.
    Urology; 1982 Sep 10; 20(3):256-8. PubMed ID: 7123717
    [Abstract] [Full Text] [Related]

  • 9. The analysis of ifosfamide and its metabolites (review).
    Kaijser GP, Korst A, Beijnen JH, Bult A, Underberg WJ.
    Anticancer Res; 1993 Sep 10; 13(5A):1311-24. PubMed ID: 8239501
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Urological implications of cyclophosphamide and ifosfamide.
    Lawson M, Vasilaras A, De Vries A, Mactaggart P, Nicol D.
    Scand J Urol Nephrol; 2008 Sep 10; 42(4):309-17. PubMed ID: 18781541
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Re: Interleukin-11 attenuates ifosfamide-induced hemorrhagic cystitis.
    Gorczynska E.
    Int Braz J Urol; 2007 Sep 10; 33(6):850-1. PubMed ID: 18199361
    [No Abstract] [Full Text] [Related]

  • 16. Re: Interleukin-11 attenuates ifosfamide-induced hemorrhagic cystitis.
    Raj A, Cheerva AC, Bertolone SJ.
    Int Braz J Urol; 2007 Sep 10; 33(6):852-3. PubMed ID: 18199362
    [No Abstract] [Full Text] [Related]

  • 17. Continuous subcutaneous administration of mesna to prevent ifosfamide-induced hemorrhagic cystitis.
    Markman M, Kennedy A, Webster K, Kulp B, Peterson G, Belinson J.
    Semin Oncol; 1996 Jun 10; 23(3 Suppl 6):97-8. PubMed ID: 8677458
    [Abstract] [Full Text] [Related]

  • 18. Ifosfamide vs cyclophosphamide in cancer therapy.
    Weiss RB.
    Oncology (Williston Park); 1991 May 10; 5(5):67-76; discussion 76-82, 84-6. PubMed ID: 1653004
    [Abstract] [Full Text] [Related]

  • 19. Chloroacetaldehyde and its contribution to urotoxicity during treatment with cyclophosphamide or ifosfamide. An experimental study/short communication.
    Pohl J, Stekar J, Hilgard P.
    Arzneimittelforschung; 1989 Jun 10; 39(6):704-5. PubMed ID: 2505783
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.